Matthew E. Dahl CV

CURRENT CLINIC ADDRESS

Ear, Nose & Throat Center
22 South 900 East
Salt Lake City, Utah 84102

Draper Office
756 East 12200
South Draper, Utah 84020

Park City Office
1820 Sidewinder Dr., Suite 110
Park City, Utah 84060

2009-Present

MEDICAL LICENSE

State of Utah (#7178394-1205)

UNDERGRADUATE EDUCATION

University California Los Angeles
Los Angeles, CA
1993-1994

Brigham Young University
Provo, Utah
1994-1999

B.S. Zoology

GRADUATE EDUCATION

Tulane University School of Medicine
New Orleans, LA
Doctor of Medicine
2000-2004

INTERNSHIP

University of Missouri Hospital
Columbus, Missouri
General Surgery
2004-2005

RESIDENCY

University of Missouri Hospital
Columbus, Missouri
Head and Neck Surgery
2005-2009

HONORS AND AWARDS

Dr. Thomas A. Giddings Humanitarian Award, 2003

Inductee into the Gold Humanism Honor Society, 2003

NCAA Academic All-American, 1998

Ace/Eagle Hardware, Award Recipient, 1998
For scholastic, community, and athletic excellence

BYU Swimming and Diving Team Captain
Golden Key National Honor Society
Four time recipient of the Academic Athlete Award
1997 -1999

PROFESSIONAL MEMBERSHIPS

Alpha Omega Alpha Medical Honor Society

American Academy of Otolaryngology Head and Neck Surgery- Resident Member

American Academy of Otolaryngology Allergy- Resident Member

PUBLICATIONS

Dahl M, Schaffer S, Wisdom GS. Inverting papilloma of the nose and paranasal sinuses. J La State Med Soc. 2003 Sep-Oct; 155(5):235~7.

Dahl M, Bothwell M. Capillary venous hemangioma of the external auditory canal associated with Sturge-Weber syndrome. Ear Nose and Throat Journal. 2007 Jan; 86 (1): 15.

Paik Y, Dahl M, Calhoun K. Update: the role of FoxP3 in allergic disease. Current Opinion in Otolaryngology Head and Neck Surgery. 2008 Jun: 16(3): 275-279.

PRESENTATIONS

Dahl M, Calhoun, K.H. Decreased Foxp3 in Allergic Patients’ Nasal Secretions. AAOA Annual Meeting. Washington DC September, 2007.

Congenital Cysts and Sinuses. August, 2005.

Vocal Ulcers, Contact Ulcer, and Granuloma. March, 2006.

Cutaneous Malignancy and Melanoma of the Head and Neck. August, 2006.

Hypopharyngeal and Laryngeal Neoplasms and Post Laryngectomy Voice Rehabilitaion. November, 2006.

Neck Dissections: The Role of Selective Neck Dissections in Head and Neck Surgery. July, 2007.

RESEARCH

Efficacy and Safety of XXX in the Treatment of Acute Peripheral Tinnitis 2 (TACTT2). 2014. Sponsored by Auris.

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2b Study of OTO-I04 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere’s Disease.
2013. Sponsored by Otonomy.

A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Phase 3 Study ofOTO- 201 Given As a Single Intratympanic Injection for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement. 2013. Sponsored by Atonomy.

Proof-of-Concept of Single Application of XXX Otic Suspension in Treatment of Acute Otitis media with Tympanostomy Tubes Compared to CIPRODEX (BID for 7 days). 2013. Sponsored by Alcon.

A 16- Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety ofIntranasal Administration of 100, 200, and 400 µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety. 2013. Sponsored by Optinose.

A 12-Month Open-Label Multicenter Study Evaluating the Safety ofIntranasal Administion of µg of :xxx Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Chronic Sinusitis With or Without Nasal Polyps. 2013. Sponsored by Optinose.

A 3-Month Open-Label Multicenter Study Evaluating the Safety of Intranasal Administration of 400 µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Chronic Sinusitis With or Without Nasal Polyps. 2013. Sponsored by Optinose.

A Clinical Evaluation oEthe Safety and Efficacy of the Steroid~Releasing XXX Sinus Implant Used in Post…;Sinus Surgery Patients with Recurrent Sinus Obstruction. 2013. Sponsored by Intersect ENT.

A Clinical Evaluation ofthe Mechanical Contribution of XXX Sinus Implant in Improving Sinus Patency and Symptoms When Used in Post-Sinus Surgery Patients with Recurrent Ethmoid Sinus Obstruction-Ethmoid Sinus Patency (ESP) Pilot Study. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of the Steroid-Eluting S8 Sinus Implant Used Following Endoscopic Sinus Surgery CESS) in Patients with Chronic Sinusitis-XXX Surgical Pilot Study. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of XXX in Improving Sinus Patency and Symptoms When Used in Post-Sinus Surgery Patients with Recurrent Ethmoid Sinus Obstruction. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of XXX Used Following Endoscopic Sinus Surgery in Patients with Chronic Sinusitis. 2012. Sponsored by Intersect ENT.

A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of XXX plus XXX compared to XXX and to XXX in the Treatment of Acute Otitis Media with Tympanostomy Tubes (AOMT) in Pediatric Patients. 2012. Sponsored by Laboratorios SALVAT, S.A.

Safety and Efficacy Evaluation of Topical XXX Otic Suspension in the Treatment of Acute Otitis Externa. 2012. Sponsored by Alcon Research, Ltd.

Topical Treatment of Acute Otitis Media through Tympaostomy Tubes (AOMT) and its Effect on Microbial Flora Distal to the Site of Infection. 2011. Alcon Research

Safety and Efficacy Evaluation of Topical XXX in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes. 2010. Sponsored by Alcon Research Ltd.

Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years. 2010, Sponsored by Alcon Research Ltd.

A Clinical Evaluation of XXX when Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis. 2009. Sponsored by Intersect ENT.

Safety of XXX in Patients with Perennial Allergic Rhinitis. 2009. Alcon Research, Ltd.

Project Title: The Role of Foxp3 in Allergic Rhinitis and Immunotherapy

Project Title: Organizing Hematoma of the Maxillary Sinus: An institutional case review.